• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Pacientes oligometastásicos: ¿hay un tratamiento diferenciado?
Pacientes oligometastásicos: ¿hay un tratamiento diferenciado?

... and polymetastatic groups in the an two-tailed Background: Fisher Exact Cancer Test). These that stagingdata and demonstrate treatment presumes abetween divisionthe intooligometastatic localized or metastatic disease. We proposed intermediate state defined by #5from cumulative termeddataset oligome ...
Prostate Cancer - Hormone Therapy
Prostate Cancer - Hormone Therapy

... Hormone Therapy for Prostate Cancer Side effects All prostate cancer treatment, including hormone therapy, carries a risk of side effects. Hormone therapy can result in erectile dysfunction, hot flashes, breast swelling, bone thinning and loss of sex drive. You may reverse the side effects of hormon ...
Document
Document

A comparative study of prostate specific antigen (PSA), C
A comparative study of prostate specific antigen (PSA), C

... previous study) were studied. However, a similar result whereby the value of the osseous metastasis-positive group was much higher than that of the osseous metastasis-negative group was seen again. Because bone metabolism markers do not signficantly improve the ability to diagnose skeletal metastasi ...
Gene Section IL6 (interleukin 6 (interferon beta 2)) in Oncology and Haematology
Gene Section IL6 (interleukin 6 (interferon beta 2)) in Oncology and Haematology

First Diagnosis Cancer
First Diagnosis Cancer

Epidemiology of Prostate Cancer and Benign Prostatic Hyperplasia
Epidemiology of Prostate Cancer and Benign Prostatic Hyperplasia

... cancer were most common among all cancer patients aged 65 years or older in 2005, and were generally high among those in their 50s or older, based on the 2005 patient survey by the Ministry of Health, Labor and Welfare (Table 1).3 ...
Relationship between Gleason score and apparent diffusion
Relationship between Gleason score and apparent diffusion

... protocol was composed of DW-MRI and dynamic contrast-enhanced imaging, in addition to a routine prostatic MRI (T2-weighted and T1-weighted imaging). DW-MRI was performed with b-values of 0 and 1000 s/mm2 along three orthogonal directions of motion-probing gradients. Automated calculation of ACD maps ...
a study in an orthotopic colorectal cancer murine model
a study in an orthotopic colorectal cancer murine model

Prostate Cancer Diagnosis Pathway
Prostate Cancer Diagnosis Pathway

Development of a Standardized Set of Patient-centered
Development of a Standardized Set of Patient-centered

... Prostate cancer is the most common noncutaneous malignancy among men and causes the death of hundreds of thousands of men each year worldwide [1]. The disease is heterogeneous, and treatment varies at each stage of disease. Although therapeutic guidelines have been developed by various organizations ...
Daniel B. Kopans, M.D. Professor of Radiology, Harvard Medical
Daniel B. Kopans, M.D. Professor of Radiology, Harvard Medical

... The authors suggestion that screening mammography finds so many cancers that would disappear if left undetected is based on false assumptions. Their thesis depends on their suggestion that the incidence of breast cancer is much higher than would have been expected had screening not been initiated. T ...
mutations in hereditary prostate cancer
mutations in hereditary prostate cancer

Cancer Prevention and Integrative Oncology
Cancer Prevention and Integrative Oncology

Announcement - ridgecresthog.com
Announcement - ridgecresthog.com

... Teams of enthusiastic citizens will gather at Burroughs High School track for an overnight relay against cancer from 9:00am on October 4 until 9:00am on October 5. Relay For Life is a unique fundraising event that allows participants from all walks of life — including patients, medical support staff ...
The High Risk Breast Cancer Clinic
The High Risk Breast Cancer Clinic

... Huntsman Cancer Institute (HCI) plays a major role in developing screening and treatment protocols for high-risk breast cancer families through participation in the National Comprehensive Cancer Network (NCCN). NCCN is a collaboration of 25 cancer centers nationwide. It works to improve the quality ...
Sample Colorectal Screening Letter
Sample Colorectal Screening Letter

... Regular colorectal cancer screenings can detect colorectal cancer early when the chances for cure are best. These screenings can also help prevent the development of colorectal cancer. In the United States, colorectal cancer is the third most common cancer in men and women with more than 130,000 new ...
Letter to Patient at Average Risk
Letter to Patient at Average Risk

... Regular colorectal cancer screenings can detect colorectal cancer early when the chances for cure are best. These screenings can also help prevent the development of colorectal cancer. In the United States, colorectal cancer is the third most common cancer in men and women with more than 103,000 new ...
SP-0110: Electrons, the lost particle: Are they still in charge?
SP-0110: Electrons, the lost particle: Are they still in charge?

... present with oligometastatic disease, where radiotherapy may find a new role with SBRT, aiming for high local control and postponing hormone treatment with potentially several years. In conclusion, in properly selected patients with recurrent prostate cancer, Choline PET/CT may guide treatment decis ...
Clinical Trial - The Prostate Net
Clinical Trial - The Prostate Net

...  What are the types/phases of clinical ...
GRID Analysis Patient Report RUO result
GRID Analysis Patient Report RUO result

... Relevant findings from published clinical studies: Patients with Decipher high risk had 77% 5 year metastasis-free survival and 70% 10 year cancer-specific survival.1,3 For these patients there was improved metastasis-free survival favoring adjuvant and early salvage postoperative radiotherapy.4-6 I ...
EphB2 SNPs and Sporadic Prostate Cancer Risk in African American Men
EphB2 SNPs and Sporadic Prostate Cancer Risk in African American Men

... familial prostate cancer among African American Men (AAM). Here we set out to test the hypothesis that common variation within the EphB2 locus is associated with increased risk of sporadic PC in AAM. We genotyped a set of 341 single nucleotide polymorphisms (SNPs) encompassing the EphB2 locus, inclu ...
GET CHECKED (MEN)
GET CHECKED (MEN)

... today! Then, become a partner with your healthcare provider to decide when you need your screenings. Share your family history, speak up, voice your concerns, and always ask questions. For instance, if your healthcare provider asks you to increase the amount you exercise, ask for examples of exercis ...
Trends in Prostate Cancer in the United States
Trends in Prostate Cancer in the United States

... die of it in 2012. Prostate cancer demographics have changed dramatically over the past 30 years. The prostate cancer age-adjusted incidence rate increased through the 1980s and peaked in the early to mid-1990s. The incidence rate has declined since. American mortality rates rose through the 1980s a ...
Vascular Endothelial Growth Factor (VEGF) and Prostate Pathology
Vascular Endothelial Growth Factor (VEGF) and Prostate Pathology

... different prostate pathologies (including benign prostatic hyperplasia, prostatitis, high grade prostate intraepithelial neoplasia and prostate cancer) in patients at high risk of prostate cancer. Materials and Methods: We consecutively enrolled 186 subjects with abnormal digital rectal examination ...
< 1 ... 66 67 68 69 70 71 72 73 74 ... 133 >

Prostate-specific antigen

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland. PSA is produced for the ejaculate, where it liquefies semen in the seminal coagulum and allows sperm to swim freely. It is also believed to be instrumental in dissolving cervical mucus, allowing the entry of sperm into the uterus.PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate cancer or other prostate disorders. The United States Preventive Services Task Force (USPSTF, 2012) does not recommend PSA screening, noting that the test may result in “overdiagnosis” and “overtreatment” because ""most prostate cancer is asymptomatic for life"" and treatments involve risks of complications including impotence (erectile dysfunction) and incontinence. The USPSTF concludes ""the potential benefit does not outweigh the expected harms."" PSA is not a unique indicator of prostate cancer, but may also detect prostatitis or benign prostatic hyperplasia. 30 percent of patients with high PSA have prostate cancer diagnosed after biopsy.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report